Page 8 - Pharma Corp News Today

Hong Kong is facing a record number of COVID-19 fatalities and battling to control a surge in cases. FDA approves cancer therapy by J&J, partner Legend Biotech The U.S. health regulator has approved a therapy developed by Johnson & Johnson and its China-focused partner Legend Biotech Corp to treat a type of white blood cell cancer, the U.S. healthcare company said on Monday.

The Food and Drug Administration's decision paves the way for Legend's first approved product in the United States, at a time when the regulator has stepped up its scrutiny of drug trials conducted in China.

Vonjo (pacritinib) is approved to treat adults with intermediate or high-risk primary or secondary myelofibrosis with a platelet count <50×109/L.

/PRNewswire/ -- The janus kinase (JAK) inhibitors market will be driven by the increasing number of awareness campaigns. The market is expected to grow by USD...

Over a two week period at the end of January and beginning of February, the U.S. Securities and Exchange Commission (“SEC” or “Commission”) proposed new rules and rule amendments that...

TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Cross-linked news, and information resources about PhaRMA

/CNW/ - (OTC PINK: INSD) Instadose Pharma Corp (the "company" or "Instadose") Establishing the world largest continual supply of Medicinal Cannabis. Instadose...

/PRNewswire/ - (OTC PINK: INSD) Instadose Pharma Corp (the "company" or "Instadose") Establishing the world largest continual supply of Medicinal Cannabis....